FDA has approved Absorica on 25 May 2012, a patented formulation of isotretinoin, as a treatment for severe recalcitrant nodular...
Sun Pharmaceutical announced that its arm Sun Pharma Canada Inc. has received Health Canada approval for Abscorba LD (isotretinoin capsules) to treat acne